Standard Model Biomedicine
PrivateLast Round
Seed
Oct 6, 2025
Company Overview
Standard Model Biomedicine operates in Healthcare & Life Sciences and is based in Philadelphia, Pennsylvania. Its latest recorded funding round was a Seed round in October 2025.
Standard Model Biomedicine is a biotechnology company that develops multimodal AI foundation models to integrate biomedical data for patient outcome prediction and clinical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Standard Model Biomedicine Comparables
Compare Standard Model Biomedicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rivercell | 85% | |
| Bioptimus | 83% | |
| Enable Medicine | 80% |
For institutional investors. Book with your work email.
Standard Model Biomedicine Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Standard Model Biomedicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Arkitekt Ventures | Seed |
| Virtue | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2025
Grew 75% QoQ, from 4 to 7 employees.
- Oct 6, 2025
Seed round led by Virtue.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingNov 8, 2026
Standard Model Biomedicine, Inc. is building The Standard Model(TM) V-2 to predict biological state across molecular, tissue, organ, and patient scales on Nov 8th '26.
- is_developingNov 8, 2026
In Nov '26, Standard Model Biomedicine, Inc. is building The Standard Model(TM) V-2, a JEPA patient world model that predicts biological state across molecular, tissue, organ, and patient scales.
For institutional investors. Book with your work email.
Standard Model Biomedicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Standard Model Biomedicine's valuation, stock price, and market status.
Is Standard Model Biomedicine a public or private company?
Standard Model Biomedicine is a private company.
What is the current stock price of Standard Model Biomedicine?
Standard Model Biomedicine is a private company, so its shares have no public market price. Caplight tracks Standard Model Biomedicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Standard Model Biomedicine worth (valuation)?
Valuation information for Standard Model Biomedicine is not publicly available.
Can I buy Standard Model Biomedicine stock?
Standard Model Biomedicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Standard Model Biomedicine's last funding round?
Standard Model Biomedicine's most recent funding round was Seed on October 6, 2025.
Who are the main investors in Standard Model Biomedicine?
Key investors in Standard Model Biomedicine include Virtue.
Will Standard Model Biomedicine IPO soon?
No public IPO plans have been announced for Standard Model Biomedicine.
How can I track Standard Model Biomedicine secondary market activity?
Caplight tracks bids, offers, and trades in Standard Model Biomedicine's shares on secondary markets.